Clinical studies for Proactol
December 6th, 2006
Below you will find the clinical studies on Proactol™ patented ingredient (NeOpuntia®) and its fat binding properties.
Proactol Clinical Data:
TNO Report Part-1 2001 – Fat binding capacity of NeOpuntia® during passage through a dynamic gastrointestinal model.
http://www.proactol-reviews.com/pdf/TNO-2001-part1.pdf
TNO Report Part-2 2004 – Fat binding capacity of xxx during passage through a dynamic gastrointestinal model.
http://www.proactol-reviews.com/pdf/TNO-2004-part2.pdf
TNO Report Part-3 2005 – Fat binding capacity of NeOpuntia® in an American breakfast meal during passage through a dynamic gastrointestinal model.
http://www.proactol-reviews.com/pdf/TNO-2005-part3.pdf
Report Part-4 – Pilot Clinical Study of NeOpuntia® on Fat Binding
http://www.proactol-reviews.com/pdf/AG-Com(latest)part4.pdf
Here is a break down of each study:
Stay tuned for the upcoming launch of the official website and for more information on Proactol.
Technorati Tags: Clinical Data, clinical study, clinically proven, fat binder, proactol, weight lossEntry Filed under: Clinical Data
Leave a Comment
You must be logged in to post a comment.
Trackback this post | Subscribe to the comments via RSS Feed